Is NLTX undervalued or overvalued?

As of 2025-03-26, the Intrinsic Value of Neoleukin Therapeutics Inc (NLTX) is -18.23 USD. This NLTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.49 USD, the upside of Neoleukin Therapeutics Inc is -622.31%. This means that NLTX is overvalued by 622.31%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-18.23 - -18.23	-18.23	-622.31%
P/E	(7.44) - (4.59)	(6.56)	-288.0%
DDM - Stable	(24.85) - (67.22)	(46.03)	-1419.1%
DDM - Multi	(37.94) - (80.88)	(51.76)	-1583.2%